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To date, it is still controversial whether memory results from an early decision to diverge 8 0 from effector fate or whether a fraction of effectors gives rise to memory cells. Recent studies 8 1 continue debating whether long-lived memory cells display an epigenetic imprint that would 8 2 correspond to an effector phenotype past (Akondy et al., 2017; Ben Youngblood et al., 2017) or 8 3
whether stemness (highest memory potential) is preserved epigenetically in antigen-primed 8 4 naïve cells that become memory cells and it is the silencing of memory / stemness genes that 1 3 8
Peripheral blood samples were collected and immediately processed for cryopreservation blood tubes after centrifugation at 1'000g for 15 min at RT followed by a second centrifugation 1 4 5 at 8'000g for 10 min at 4 o C. 
Assay to determine copy numbers of the Yellow Fever virus YF-17D
1 4 8
Yellow Fever virus (YFV) load was quantified using 1ml of plasma from EDTA-anticoagulated points' vials contained 10e7 frozen PBMC -the complete volume of stained samples was 1 7 0 finally acquired. Cytometers were the Gallios (Beckman Coulter, 3 laser, 10-color) and the 1 7 1 LSR II Special Order Research Product (Beckton Dickinson, 5 laser including UV, 13-or 14-1 7 2 color). Before each acquisition, the cytometer setup and tracking (CST) was ran in order to which is 1.5-fold larger (1.5 x 10e7 PBMC thawed). The detection threshold for multimer 1 8 3 positive populations was 0.01% of total CD8 T cells and at least 10 events (horizontal dotted 1 8 4 line in Figure 1C and D), based on control stainings using HLA-A*02 negative samples stained vaccine virus YF-17D was detectable at days 3 and/or 7 in the plasma of five out of the eight 2 4 5 vaccinees ( Figure 1D and Figure S1 ). The analysis was challenged by the fact that A2/LLW 2 4 6 multimer positive cells were close to the limit of detection at baseline and at days 3 and 7 (only 2 4 7 samples that showed total A2/LLW+ CD8 T cells superior to 0.01% of total CD8 T were 2 4 8 further analyzed for subset distribution). In two donors, CM (in donor LAU 5088) and both CM 2 4 9
and SCM (in donor LAU 5080) cells were detected at the same time-point when virus was 2 5 0 detectable ( Figure S1 ). These data show that cells with a memory phenotype can arise before 2 5 1 antigen is cleared, well ahead of the contraction phase of the response. In parallel to the rise in frequencies, the acute phase of the T cell response is characterized 2 5 7 by the expression of activation markers as previously described in total A2/LLW+ CD8 T cells 2 5 8 (Akondy et al., 2009; Blom et al., 2013; Querec et al., 2009) . In order to address how activation 2 5 9 status compared across CD8 T cell subsets, we measured the longitudinal expression of 2 6 0 activation markers: CD69, CD38, HLA-DR and PD1, within each subset. At the peak of the 2 6 1 response (day 14), the analyses clearly showed that the CCR7+ memory subsets (SCM and 2 6 2 CM) were extensively activated, in fact as much as the CCR7-EM and EMRA subsets ( 2). The early activation marker CD69 was most highly expressed at days 3 and 7, while HLA-2 6 4 DR, CD38 and PD1 peaked at day 14 ( Figure S2 ). Beyond day 14, CD38 clearly diminished 2 6 5 while HLA-DR and PD1 partially persisted ( Figure S2 ). Of note, in the aforementioned longitudinal analyses, we observed that A2/LLW+ CD8 T 2 6 8 cells were still present in the Naïve gate (as defined by CCR7+ CD45RA+ CD95-) after vaccination and that they remained relatively stable over time ( Figure 1 ). Interestingly, these 2 7 0 post-vaccination Naïve cells did show substantial activation at the peak of the response ( Figure   2 7 1 2 and S2). The nature of these Naïve-gated cells will be discussed. by analyzing resting total CD8 T cells in a large number of donors (N=33), we observed a wide data in N=33 donors revealed that the fraction of TCF1+ cells was widely variable within 2 8 7 CCR7-subsets across donors (EM and EMRA, Figure 3C and D). We then analyzed TCF1 expression in A2/LLW-specific CD8 T cells at various time-2 9 0 points following vaccination with YF-17D. In order to assess the early and very long-term 2 9 1 phases of the response, we analyzed samples from the longitudinal cohort (N=8, up to 6 months 2 9 2 post-vaccination) together with samples from the cross-sectional cohort (N=26, up to 23.7 2 9 3 years post-vaccination, Table S1B : "Cross-sectional cohort : YF1 study" and Figure S3 ). In the 2 9 4 first weeks, TCF1 positive frequencies sharply dropped in CCR7-subsets (EM and EMRA, 2 9 5 Figure 4A and B), proving TCF1 downregulation during the acute response in humans in vivo. The maximum drop in TCF1 occurred at day 28 ( Figure 4A and B), and appeared thus delayed 2 9 7
relative to the activation peak at day 14 ( Figure S2 ). After day 28, the CCR7-populations (EM 2 9 8 or EMRA) showed a gradual increase in the percentages of TCF1+ cells, particularly visible in 2 9 9
the decade-persisting EM and EMRA cells ( Figure 4B ). In contrast, we observed that TCF1 profile of TCF1 downregulation compared to TCF1 maintenance in CCR7+ subsets (Naïve, 3 0 5 SCM, and CM) ( Figure 4C ). While CM cells showed a trend closer to the trends in Naïve and 3 0 6 SCM, they were statistically distinct to all subsets; the trends of Naïve and SCM were not Within the CCR7-subsets, we addressed whether the increase in the percentage of TCF1+ 3 1 0 cells in the longer-term was linked to an overall or a relative increase in TCF1+ cells. We to the total CD8 T cells and from the peak of the response (day 14). We observed that : a) both 3 1 3 TCF1+ and TCF1-populations declined with time ( Figure 4D ), and b) TCF1+ populations 3 1 4
declined less than TCF1-populations ( Figure 4D and E), in both EM and EMRA subsets. Rather than re-expression of TCF1 in CCR7-cells, these relative frequencies suggest that 3 1 6 TCF1+ cells persist better than TCF1-cells in the long-term. We further studied the expression of the Interleukin 7 Receptor alpha chain (IL7Ra) in the 3 1 9
EMRA subset and found a pattern of IL7Ra expression globally correlated to TCF1 expression fraction of IL7Ra+ in total EMRA), the TCF1 and IL7Ra co-enrichment was not significant; 3 2 5 CCR7+ subsets express high levels of IL7Ra similar to high levels of TCF1+ (data not shown).
2 6
This is in line with our previous analysis where A2/LLW-specific EMRA but not A2/LLW-3 2 7 specific EM showed significant enrichment of the IL7Ra as compared to their counterparts in 3 2 8 total CD8 T cells (Fuertes Marraco et al., 2015) . In order to detail the dynamics of the CD8 T cell response including multiple 3 3 5 differentiation and activation markers, we applied multi-dimensionality reduction and 3 3 6
unsupervised clustering to flow cytometry data using t-distributed Stochastic Neighbor Embedding (tSNE), and then further generated time-lapse representations. We applied this described SCM subset, the existing evidence is limited to one study using the macaque model due to the medical restrictions for blood withdrawals that precluded closer intervals in our 3 9 3 study. Nevertheless, two donors showed rising memory cells as early as day 3 and 7, while 3 9 4
virus was still detectable (day 3). Our data clearly exclude that memory subsets appear only 3 9 5
once the antigen is cleared or after the acute peak, and provide evidence that cells with a 3 9 6 memory phenotype establish early after priming, within the acute phase. The particular value of this human experimental evidence is highlighted by the challenge 3 9 9
in studying memory development based on phenotypic markers, and the fact that these markers 4 0 0 globally vary between mouse and human systems. In the mouse, the major differentiation 2008)), ii) IL2Rb is higher in SCM but requires visualization with a second marker for 4 1 4
Naïve/SCM discrimination, in contrast to the distinct CD95+ staining of SCM cells versus 4 1 5 CD95-signal in naïve cells (Gattinoni et al., 2011) , and iii) CXCR3 shows high inter-donor 4 1 6 variability and substantial positive signal even in cells that are CD58 and CD95 negative such 4 1 7
as Melan-A-specific CD8 T cells in healthy donors, which are predominantly naïve (Fuertes 2015)) and mouse models are largely used to study CD8 T cell differentiation. Notwithstanding, the discrepancy of differentiation markers used in different model systems Historically, it has been particularly challenging to distinguish SCM from Naïve cells: SCM this antigen specificity, sufficiently rapid to immediately replenish the cells that have been 1 6
preserve highest "naïveness", we hypothesize that the cells that remain in the naïve gate after 4 4 9
priming may have been effectively primed but are memory cells that preserve a phenotype that (Naïve) located at baseline. We observed YF-specific CD8 T cell subsets with phenotypes of cells, and each of these subsets showed activation at the peak of the response and phenotypically close to the naïve baseline and distinct from the burst of effector subsets at the 4 7 0 peak of the response. Along these lines, a study in mice showed that CD8 T cells that have shows phenotypic heterogeneity also in the very long-term, evidenced by the fact that EMRA denotes a non-detectable population) and the total CD8 T cell reference in grey fill below. populations of A2/LLW-specific EM or EMRA subsets amongst total peripheral CD8 T cells. Corresponding linear regressions with least squares fit are shown for data from the peak of the from each donor were downsampled to 5'000 events and the sum of N=13 donors were 7 7 4 6
and Day 185 (ca. 6 months) after YF-17D vaccination. Each sequence is spaced by 1 second,
and shows subset overlay or the indicated heatmapped marker. All the single live A2/LLW-8 1 1 specific CD8 T cell events acquired were concatenated and ran for the 9-marker tSNE. detectable Yellow Fever viral load. Data are quantified as in Figure 1D , showed for each 8 1 5
individual donor that showed positive Yellow Fever viral load (N=5 out of 8 donors). longitudinal cohort). panel configuration ("panel D", see Table S2 ). subsets further gated and color-coded as detailed in Figure 6A. (B showing the heatmap (based on median) of each marker, as indicated. * (p = 0.0176) ** (p = 0.0028) * (p = 0.0218) ns (p = 0.1105) ns (p = 0.1195) ** (p = 0.0094) ns (p = 0.326) Baseline EMRA 
